Cargando…
Harnessing the Potential of NK Cell-Based Immunotherapies against Multiple Myeloma
Natural killer (NK) cell-based therapies have emerged as promising anticancer treatments due to their potency as cytolytic effectors and synergy with concurrent treatments. Multiple myeloma (MM) is an aggressive B-cell malignancy that, despite development of novel therapeutic agents, remains incurab...
Autores principales: | Reina-Ortiz, Chantal, Giraldos, David, Azaceta, Gemma, Palomera, Luis, Marzo, Isabel, Naval, Javier, Villalba, Martín, Anel, Alberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8834301/ https://www.ncbi.nlm.nih.gov/pubmed/35159200 http://dx.doi.org/10.3390/cells11030392 |
Ejemplares similares
-
Expanded NK cells from umbilical cord blood and adult peripheral blood combined with daratumumab are effective against tumor cells from multiple myeloma patients
por: Reina-Ortiz, Chantal, et al.
Publicado: (2020) -
Expanded and activated allogeneic NK cells are cytotoxic against B-chronic lymphocytic leukemia (B-CLL) cells with sporadic cases of resistance
por: Calvo, Tania, et al.
Publicado: (2020) -
Immunogenic Cell Death and Immunotherapy of Multiple Myeloma
por: Serrano-del Valle, Alfonso, et al.
Publicado: (2019) -
Response: Commentary: Immunogenic Cell Death and Immunotherapy of Multiple Myeloma
por: Serrano Del Valle, Alfonso, et al.
Publicado: (2019) -
Ecto-calreticulin expression in multiple myeloma correlates with a failed anti-tumoral immune response and bad prognosis
por: Serrano Del Valle, Alfonso, et al.
Publicado: (2022)